• Upward mobility is a myth. It’s an axiom among many Americans that each future generation will live better than its predecessor. Among many young Americans, however, there is downward mobility. The children aren’t achieving what they
  • Childhood cancer survivors face ‘financial toxicity’. A new study by investigators at St. Jude Children's Research Hospital suggests that many survivors of childhood cancer are struggling with the economic consequences, also called “financial toxicity.” The research, in the
  • Consumer Action INSIDER - August 2018. This month's INSIDER updates readers on recent events (including Public Citizen's Affordable Medicines Now conference, the Transatlantic Consumer Dialogue’s annual meeting on the impact of technology on consumers, and the Credit Builders Alliance Training Institute); breaks down the pros and cons of a new California data protection law; tells the tale of a consumer who was charged too much for her out-of-country car rental due to "currency conversion" issues; updates readers on the latest happenings at the Consumer Financial Protection Bureau (which is currently under assault by its own director); gives information on our "coalition efforts" and lists the latest lawsuit settlements from our Class Action Database.
  • The top 10 things consumers complained about in 2017. False advertising of new and used cars, shoddy home improvement work, and deceptive retail sales tactics lead the towering list of complaints that consumers submitted last year. A new annual Consumer Federation of America (CFA)


  • Things you don't know about credit card travel insurance (Chinese). 旅遊保險值得買嗎?見仁見智。近謂保險,就是保障未知之險;如果你手上一張信用卡也沒有,或者機票不是用信用卡付款買的,請你一定要買旅遊平安險。但如果你手上有一堆信用卡,買機票前不妨研究看看,哪些卡提供旅遊保險;如果能同時累積哩程或點數還可以享有事故發生時的保險理賠,一舉兩得。
  • The truth about ‘breakthrough’ drugs. A new study published in the Journal of the American Medical Association digs deeply into the studies behind the flood of “breakthrough” therapies that have been approved by the Food and Drug Administration
  • The news on drug prices? Nothing good. It has been two months since the president released his road map for lowering drug costs that seems to lead nowhere, and about a month since he predicted the “big drug companies” would

Quick Menu

Support Consumer Action

Support Consumer

Join Our Email List

Optional Member Code
Facebook FTwitter T

Insurance Menu

Help Desk